Vancouver, BC / January 21, 2021, / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC). The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one […]
BIOHARVEST SCIENCES INC. ANNOUNCES PRIVATE PLACEMENT Read More »
Vancouver, BC / January 20, 2021 / BioHarvest Sciences Inc. (the “Company” or “BioHarvest”) (CSE: BHSC) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event
Vancouver, BC / January 13, 2021 / BioHarvest Sciences Inc. (the “Company” or “BioHarvest”) (CSE: BHSC) announces that it has created a new board of scientific advisors to assist the Company in capitalizing on its proprietary BioFarming technology. The mandate of the Scientific Advisory Board (“SAB”) is to advise and guide the Company as it
Vancouver, BC / January 12, 2021 / BioHarvest Sciences Inc. (the “Company”, “BioHarvest”) (CSE: BHSC) announces that is has granted of a total of 765,000 stock options to consultants. The stock options granted are exercisable to purchase a common share of the Company at a price of $0.36 per share for a term of 10
BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS Read More »
Vancouver, BC / January 7, 2021. Driven by the high demand in Israel, BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) reports that its Q4 sales orders for VINIA®, the Company’s proprietary red grape cell dietary supplement and functional food, have exceeded the earlier Q4 sales order forecast for the quarter. BioHarvest’s new e-commerce program
